Skip to content
Homepage
Clinic directory

Clinics in Boston, Connecticut

Every listing is checked against federal records, reviewed for evidence, and confirmed still operating. No pay-to-play. No guesswork.

  • No results found.
  • No results found.

Boston, CT

Peptide Therapy clinics in Boston

Boston has Harvard-affiliated academic medicine and some of the country's strictest pharmacy oversight after the 2012 NECC outbreak, and peptide therapy has grown into a visible slice of the local wellness market. The clinics we track across Back Bay, Beacon Hill, Cambridge, and Brookline range from physician-led longevity practices to medspa-adjacent wellness offices offering sermorelin blends and growth hormone peptides. Most local prescribers have training or admitting privileges within the Mass General Brigham, BIDMC, and Tufts Medical Center network. The scene here skews toward academic-trained physicians running conservative peptide protocols with rigorous monitoring. The regulatory landscape shifted sharply in 2023 and 2024 when the FDA placed several widely prescribed peptides on its Category 2 bulk substances list, restricting which ingredients compounding pharmacies could legally source. That changed access overnight for BPC-157, CJC-1295, ipamorelin, and thymosin beta-4. Sermorelin and tesamorelin remain FDA-approved for specific indications, and reputable Boston clinics now draw a clearer line between approved peptides and off-label research compounds than they did two years ago.

No clinics found

Try adjusting your filters or search terms

Reset all filters

Regulatory context

A note on Connecticut's peptide therapy rules.

Most research peptides used in regenerative medicine (BPC-157, TB-500, CJC-1295, ipamorelin) are not FDA-approved drugs. Sermorelin and tesamorelin hold FDA approvals for specific indications. During 2023 and 2024 the FDA placed several peptides into Category 2 on its Bulk Drug Substances Nominated for Use in Compounding list, which limits 503A compounding pharmacies from sourcing those ingredients. Section 503A covers patient-specific compounding; Section 503B covers FDA-registered outsourcing facilities held to cGMP.

  • Connecticut General Statutes Chapter 400j (Pharmacy)
    Governs compounding and pharmacy licensure under the Connecticut Commission of Pharmacy.
  • Connecticut General Statutes Chapter 370 (Medicine and Surgery)
    Regulates physician practice and prescribing.
  • Connecticut General Statutes Section 20-34 (Naturopathy)
    Licenses NDs with a limited formulary; prescribing injectables generally requires physician collaboration.

The Connecticut Department of Consumer Protection Drug Control Division oversees pharmacy inspections and enforces USP 795 and USP 797 standards. Non-resident pharmacies shipping peptides into Connecticut require a current state license. Compounding facilities that source ingredients inconsistent with FDA bulk list rules can face disciplinary action.

Sources: fda.gov · portal.ct.gov · portal.ct.gov

Peptide Therapy in Boston, answered.

Boston clinics most commonly offer sermorelin and sermorelin plus ipamorelin blends for growth hormone support, both of which are FDA-approved for adult GH deficiency. Healing peptides like BPC-157 and thymosin beta-4 (TB-500) are sometimes offered, but neither is FDA-approved and both landed on the FDA's Category 2 bulk list in 2023, which restricts compounding pharmacy sourcing. CJC-1295 and tesamorelin (Egrifta) appear in some protocols; tesamorelin is FDA-approved for HIV-associated lipodystrophy only. Melanotan II, epithalon, and selank are not FDA-approved.

$450 to $700 per month for sermorelin or sermorelin plus ipamorelin blends. $600 to $1,100 per month for BPC-157 plus TB-500 protocols when available through compounding. $550 to $950 per month for peptide plus hormone optimization bundles. Expect $400 to $900 upfront for initial labs (CBC, CMP, IGF-1, hormone panel, inflammatory markers) and the intake consult. Most clinics expect a 3 to 6 month commitment with monthly or quarterly follow-ups, and injection supplies and shipping from the compounding pharmacy are usually bundled into the monthly price.

Sermorelin and tesamorelin are FDA-approved for specific indications, so those are the only peptides a Massachusetts clinic can prescribe as standard practice with full FDA backing. BPC-157, CJC-1295, ipamorelin, thymosin beta-4 (TB-500), epithalon, melanotan, and most other research peptides are not FDA-approved. The FDA's 2023-2024 Category 2 bulk substances list decision meant 503A compounding pharmacies lost legal access to many of those ingredients, so availability fluctuates. Any Boston clinic that still offers a long menu of non-approved peptides should disclose exactly where those ingredients come from.

Massachusetts grants nurse practitioners full practice authority, so NPs can evaluate, prescribe, and manage peptide protocols independently. Compounding pharmacy partnership remains required for custom peptide prescriptions, and most clinics work with a 503A pharmacy licensed in the state. The Massachusetts Board of Registration in Medicine licenses physicians and the Massachusetts Board of Pharmacy enforces some of the country's strictest sterile compounding rules following the 2012 NECC meningitis outbreak. Peptides are typically administered by subcutaneous injection at home after a training session at the clinic, though some Boston offices offer in-clinic injections. Be wary of non-clinical operators selling peptides labeled as research chemicals, which is a federal red flag regardless of state law.

Verify the prescribing physician's active license through the Massachusetts medical board and confirm their NPI number through the NPPES registry. Ask which 503A compounding pharmacy supplies the peptides and whether that pharmacy is licensed in Massachusetts. Request baseline labs (CBC, CMP, IGF-1, hormone panel, inflammatory markers) before starting any growth hormone peptide, and confirm a monitoring schedule. Reputable Boston clinics in Back Bay will clearly distinguish FDA-approved peptides from off-label compounds and avoid marketing research chemicals to the public.

Treatment guide

Learn about Peptide Therapy

What it is, how it works, and what to expect.

Filters

Rating

Treatments

Advanced Therapies 1
Chronic, Immune & Hormonal
Digestive & Respiratory
IV & Infusion
Pain & Musculoskeletal
Skin & Aesthetics
Mental Health & Neurology